$85.07 +0.80 (%) Pacira Pharmaceuticals Inc - NASDAQ

Apr. 24, 2015 | 04:00 PM

Partner Headlines

  1. Pacira Pharmaceuticals'

    IBD | Mar. 2, 2015 | 18:45PM EST
  2. Stocks Tack On Gains; Nasdaq Tops 5000 Level

    IBD | Mar. 2, 2015 | 12:01PM EST
  3. Morning Market Losers

    Benzinga | Mar. 2, 2015 | 09:55AM EST
  4. Benzinga's Top #PreMarket Losers

    Benzinga | Mar. 2, 2015 | 08:19AM EST
  5. JPM Securities Picks Through Biotech News For Winners

    Benzinga | Feb. 25, 2015 | 12:41PM EST
  6. Pacira Pharmaceuticals

    IBD | Feb. 24, 2015 | 19:07PM EST
  7. Why These Three Hot Young Stocks Are Worth Watching

    IBD | Feb. 24, 2015 | 17:25PM EST
  8. Stocks Edge Lower, Oil Falls, But Managed-Care Firms Shine

    IBD | Feb. 23, 2015 | 11:47AM EST
  9. 3 Niche ETFs Breaking Out

    Benzinga | Feb. 17, 2015 | 14:42PM EST
  10. More Leading Stocks Showing Better Action

    IBD | Feb. 11, 2015 | 17:50PM EST
  11. Stocks Mixed, Mostly Unchanged; Apple Extends Gains

    IBD | Feb. 11, 2015 | 14:58PM EST
  12. Stocks Mixed In Quiet Session; Pacira, Zoetis Ramp Higher

    IBD | Feb. 11, 2015 | 13:26PM EST
  13. Stocks Stay Mixed; Palo Alto Breaks Out

    IBD | Feb. 11, 2015 | 11:49AM EST
  14. US Stock Futures Edge Lower Ahead Of Earnings

    Benzinga | Feb. 11, 2015 | 07:26AM EST
  15. Wedbush Highlights 2015 Catalysts for Emerging BioPharmaceuticals

    GuruFocus | Feb. 4, 2015 | 13:43PM EST
  16. New Biotech ETF From ALPS

    Benzinga | Jan. 2, 2015 | 08:05AM EST
  17. Pacira Pharma Reports Changes to EXPAREL Label, Indication Not Affected

    Benzinga | Dec. 12, 2014 | 08:33AM EST
  18. SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Pacira ...

    GuruFocus | Nov. 28, 2014 | 11:03AM EST
  19. New Study Correlates Use Of EXPAREL For Postsurgical Pain Management With Significant Reductions In Opioid Related Adverse Events

    Benzinga | Oct. 27, 2014 | 16:13PM EST
  20. Bank Of America Q3 Small & Mid-Cap Biotech Preview

    Benzinga | Oct. 20, 2014 | 16:58PM EST
  21. Pacira Pharma Offers Added Data Support Safety of EXPAREL in Peripheral Nerve Block

    Benzinga | Oct. 13, 2014 | 16:00PM EST
  22. Bank Of America Sees Significant Manufacturing Capacity Expansions Underway For Pacira Pharmaceuticals

    Benzinga | Oct. 8, 2014 | 11:13AM EST
  23. NASDAQ Dips 1.5%; HB Fuller Shares Decline On Downbeat Results

    Benzinga | Sep. 25, 2014 | 12:09PM EST
  24. Markets Tumble; Scholastic Posts Wider Fiscal-First Quarter Loss

    Benzinga | Sep. 25, 2014 | 11:12AM EST
  25. Morning Market Losers

    Benzinga | Sep. 25, 2014 | 09:44AM EST
  26. Benzinga's Top #PreMarket Losers

    Benzinga | Sep. 25, 2014 | 08:11AM EST
  27. US Stock Futures Flat Ahead Of Jobless Claims, Durable-Goods Orders Data

    Benzinga | Sep. 25, 2014 | 07:35AM EST
  28. Pacira Pharmaceuticals, Inc. Announces Receipt of FDA Warning Letter

    Benzinga | Sep. 25, 2014 | 06:59AM EST
  29. Pacira Pharmaceuticals

    IBD | Jul. 31, 2014 | 18:53PM EST
  30. UPDATE: Bank Of America Reiterates On Pacira Pharmaceuticals On Positive Survey Results

    Benzinga | Jul. 17, 2014 | 08:33AM EST
  31. 3 Hot Biotech Stocks Hitting Highs

    Benzinga | Jun. 23, 2014 | 14:00PM EST
  32. UPDATE: JMP Securities Initiates Coverage On Pacira Pharmaceuticals

    Benzinga | Jun. 17, 2014 | 10:43AM EST
  33. Sohn Conference Moves Markets Once Again

    Benzinga | May. 6, 2014 | 16:56PM EST
  34. Benzinga's Volume Movers

    Benzinga | Apr. 9, 2014 | 10:22AM EST
  35. CorMedix Welcomes Additional Board Members

    Benzinga | Apr. 7, 2014 | 08:33AM EST
  36. Mid-Morning Market Update: Markets Open Higher; UTi Worldwide Reports Q4 Loss

    Benzinga | Mar. 31, 2014 | 10:35AM EST
  37. Baron Funds Comments on Pacira Pharmaceuticals

    GuruFocus | Mar. 5, 2014 | 11:26AM EST
  38. UPDATE: Piper Jaffray Downgrades Pacira Pharmaceuticals Following 2Q13 Net Loss

    Benzinga | Aug. 7, 2013 | 08:18AM EST
  39. Pacira Pharma Shares Sink as Co. Announces EXPAREL Phase 3 Trial Does Not Meet Primary Endpoint

    Benzinga | Aug. 1, 2013 | 17:36PM EST
  40. UPDATE: Jefferies & Company Reiterates Buy Rating, Raises PT on Pacira Pharmaceuticals

    Benzinga | Jan. 18, 2013 | 03:52AM EST
  41. Pacira Pharma Prices $110M Private Offering of Convertible Notes

    Benzinga | Jan. 17, 2013 | 01:07AM EST
  42. Pacira Pharmaceuticals Announces Proposed Offering of $100 Million of Convertible Senior Notes

    Benzinga | Jan. 15, 2013 | 09:00AM EST
  43. Health Care Sector Wrap

    FoxBusiness | Aug. 28, 2012 | 10:43AM EST
  44. Health Care Sector Wrap

    FoxBusiness | Aug. 14, 2012 | 10:46AM EST
  45. Health Care Sector Wrap

    FoxBusiness | Aug. 9, 2012 | 10:40AM EST
  46. Dollar General, Questcor Pharmaceuticals Among Stocks Setting 52-Week Highs Monday

    FoxBusiness | Jun. 25, 2012 | 10:33AM EST
  47. Arena Pharmaceuticals, Merck &, Other Stocks Hit 52-Week Highs Thursday

    FoxBusiness | Jun. 21, 2012 | 06:33AM EST
  48. Pacira Pharmaceuticals Announces EXPAREL Expected to be Commercially Available in April 2012

    Benzinga | Jan. 8, 2012 | 23:51PM EST
  49. Pacira Pharmaceuticals Announces Results from EXPAREL Pivotal Trial Published in Diseases of the Colon & Rectum

    Benzinga | Dec. 18, 2011 | 23:52PM EST
Trading Center